Health & Personal Care
HIGH
FDA DRUG
Quallent Pharmaceuticals Health LLC Recall Expands for Duloxetine Delayed-Release Capsules Over Imp-
Breckenridge Pharmaceutical recalls duloxetine delayed-release capsules due to CGMP deviations raising N-nitroso-duloxetine impurity above interim limit. The bottles were distributed to Arizona, Indiana and New Jersey. Consumers should stop using the product and contact their healthcare provider for guidance.
DULOXETINE
CGMP deviations: